Loading clinical trials...

Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial | Clinical Trials | Clareo Health

RECRUITINGPhase 2NCT05758246

Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial

The long-term goal is to test the clinical efficacy of senolytic therapies to reduce progression to and severity of sepsis in older patients. The central hypothesis is that a threshold burden of SnCs ...

Lead sponsor: University of Minnesota•10 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Michael Puskarich, MD

CONTACT

612 626 6911 mike-em@umn.edu

Related studies

RECRUITINGPhase 4

Aminoglycosides in Early Sepsis

NCT06712641 · Sepsis

RECRUITING

ACOD1 as a Prognostic Marker for Sepsis

NCT07533994 · Sepsis

RECRUITINGNA

Peripheral Perfusion Index-guided Fluid Resuscitation for Preventing Acute Skin Failure in Elderly Critically Ill Patients

NCT07367113 · Sepsis, Septic Shock, and more

RECRUITING

Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on Echovirus 11

NCT07356583 · Enterovirus, Clinical Syndrome, and more

RECRUITING

QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

NCT06517810 · Acute Kidney Injury, Acute Kidney Injury Due to Sepsis

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 15, 2025Terms

Trial snapshot

StatusRECRUITING

PhasePHASE2

Enrollment220

Start dateAug 2023

Last updatedOct 15, 2025

Condition

Sepsis Acute Infection Organ Failure

Locations shown

University of Florida

Gainesville, Florida

University of Iowa

Iowa City, Iowa

Ridges

Burnsville, Minnesota

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 15, 2025Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Senolytics To slOw Progression of Sepsis (STOP-Sepsis) Trial

What this study is about

Clareo turns complex medical information into clear understanding you can use.

Contacts

Sponsors

Related studies

Aminoglycosides in Early Sepsis

ACOD1 as a Prognostic Marker for Sepsis

Peripheral Perfusion Index-guided Fluid Resuscitation for Preventing Acute Skin Failure in Elderly Critically Ill Patients

Neonatal Enterovirus Infections in Italy: Virological Characterization, Genomic and Clinical-epidemiological Insights on Echovirus 11

QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry

Trial snapshot

Condition

Locations shown

For caregivers